Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone

NCT06047912 is registered in ClinicalTrials.gov with Dr Ian B Wilkinson as lead sponsor.

NCT NCT06047912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
Lead sponsor
Dr Ian B Wilkinson
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2023
Completion date
December 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, primary aldosteronism, urine aldosterone